ACHE and Hepatic fibrosis: In addition, among all common targets for RGGs and liver fibrosis, ESR1, ESR2, AR, ACHE, CYP19A1, and AKR1B1 have a high degree of interaction with other targets and some active compounds (Figure 3F).